Vol. 08. Check out Conference Topics & Keynote Session with MIT!
▶2024 Conference Preview
"Embrace All Possibilities"
Embark on an exploration of boundless possibilities at the BIX Conference,
igniting innovation within the bio-pharma industry and steering it towards a sustainable future.
'Collaboration' stands as a cornerstone, offering invaluable opportunities as bio-pharma enterprises navigate novel pathways of innovation. BIX 2024 boasts a lineup of 36 diverse sessions,
featuring 130 speakers,fostering dynamic discussions and catalyzing the establishment of pragmatic partnerships.
Conference Session Topics
[Regulatory] [Technology] [Finance] [Business]
The Program at a Glance, featuring the themes of all sessions will be unveiled
in the end of April. Stay tuned for an exciting reveal!
▶Keynote Speech Ⅰ
2024 BIX Conference - Keynote Session Revealed!
Introducing Keynote Session Ⅰ with top experts in Chemical Manufacturing Engineering.
Delve into the significance and future growth potential of mRNA biotherapeutics,
providing insights into advancements in pharmaceutical manufacturing technology.
▶Topic◀
The Current Status and Promise of mRNA Biotherapeutics
[DAY 1] July 10, 2024 ┃9:30 - 10:10 (40')┃Conference Room 401, COEX
▶Overview◀
The value of mRNA biotherapeutics was demonstrated for the mRNA-based COVID-19 vaccine that was developed for the last pandemic. The ability to quickly produce a biotherapeutic via cell-free synthesis enables the potential of greatly reducing process development speed – which was critical during the pandemic – but only the potential for reduced production and purification costs. This presentation will discuss the current status and promise for both vaccine and non-vaccine biotherapeutic applications.
▶Speaker◀
Professor Richard D. Braatz is an internationally recognized researcher, honored with the American Institute of Chemical Engineers (AIChE) Innovation Award, along with numerous publication and investigator awards.
His expertise spans bio-pharmaceutical manufacturing, data analytics and machine learning,
applied mathematics, and control theory.
Dr. Braatz and his colleagues at MIT are driving advancementsin the biopharmaceutical industry, notably through projects like designing the world's first fully integrated continuous mRNA manufacturing platform, funded by the U.S. Food and Drug Administration (FDA).
▶SAVE YOUR SPOT! Booth Application D-7
|
🌎 INTERPHEX US
🌎 API CHINA
BIOPLUS-INTERPHEX KOREA
[email protected]
1622-24, Block A, Terra Tower 2, 201, Songpa-daero, Songpa-gu, Seoul, Korea
+82 2-561-6169